300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Recruiting
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Nigeria
Tajikistan
Zimbabwe
Isle of Man
Pakistan
Cameroon
Romania
Oman
Colombia
India
Australia
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Germany
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United Kingdom
United States
Canada
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Ireland
Peru
Slovenia
San Marino
Ukraine
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical Device VC Funds & Investors in China (June 2026)

The most active venture capital funds investing in China Medical Device startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in China Medical Device startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Qiming Venture Partners
VC Fund
13 China, United States, Hong Kong Series B, Series A, Series C Health Care, Biotechnology, Medical $5M–$142M
Cowin Capital
VC Fund
13 China, Hong Kong, United States Series A, Series B, Seed Manufacturing, Health Care, Biotechnology $1.4M–$50M
HSG
VC Fund
12 China, United States, Hong Kong Series A, Series B, Series C Health Care, Biotechnology, Software $4.4M–$214M
Shunwei Capital
VC Fund
11 China, United States, India Series A, Series B, Series C Manufacturing, Software, Internet $1.4M–$130M
BioVenture
VC Fund
11 China, United States, Hong Kong Series A, Series B, Seed Health Care, Medical, Biotechnology $1.9M–$73M
CD Capital
VC Fund
10 China, United States Series A, Series B, Seed Health Care, Biotechnology, Medical Device $1.4M–$34M
Lilly Asia Ventures
VC Fund
10 China, United States, Hong Kong Series A, Series B, Series C Biotechnology, Health Care, Medical $14M–$259M
BIOCHING CAPITAL
VC Fund
9 China Angel, Series A, Seed Medical, Medical Device, Biotechnology $425k–$100M
BioTrack Capital
VC Fund
9 China, United States, Singapore Series A, Series B, Seed Biotechnology, Health Care, Medical $3M–$168M
Taiyu Investment
VC Fund
8 China Seed, Series A, Angel Medical, Health Care, Biotechnology $4.3M–$37M
Addor Capital
VC Fund
8 China, Hong Kong, Singapore Series A, Series B Manufacturing, Semiconductor, Electronics $1.4M–$43M
Haibang Capital
VC Fund
8 China Series A, Angel, Series B Health Care, Biotechnology, Manufacturing $425k–$71M
IDG Capital
VC Fund
8 China, United States, India Series A, Series B, Series C Software, Internet, E-Commerce $3M–$200M
Med-Fine Capital
VC Fund
7 China, Hong Kong, United States Series A, Seed, Series B Medical, Health Care, Biotechnology $2.8M–$60M
Legend Capital
VC Fund
7 China, United States, South Korea Series B, Series A, Series C Health Care, Medical, Biotechnology $2.8M–$200M
Dalton Venture
VC Fund
7 China, India, Canada Seed, Series A, Series B Health Care, Medical, Biotechnology $450k–$47M
Prox Ventures
VC Fund
7 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $1.9M–$28M
Oriza Seed Capital (Oriza Yuandian)
VC Fund
7 China, United States, Singapore Series A, Seed, Angel Manufacturing, Health Care, Medical $213k–$90M
EFung Capital
VC Fund
7 China, United States, India Series B, Series A, Series C Health Care, Biotechnology, Medical $1.4M–$87M
CDH Investments
VC Fund
6 China, United States, Canada Series A, Series B, Series C Manufacturing, Health Care, Biotechnology $7.3M–$300M
Haiyuan Capital
VC Fund
6 China Series A, Seed, Angel Manufacturing, Medical, Semiconductor $425k–$55M
SND Ventures Group
VC Fund
6 China Series A, Series B, Seed Manufacturing, Semiconductor, Health Care $1.4M–$31M
Highlight Capital
VC Fund
6 China, United States, Portugal Series A, Series B, Seed Health Care, Medical, Biotechnology $2.8M–$73M
Matrix Partners China
VC Fund
6 China, United States, Hong Kong Series A, Series B, Seed Health Care, Biotechnology, Software $1.4M–$108M
Marathon Venture Partners
VC Fund
6 China, United States, Hong Kong Series A, Series B, Seed Health Care, Medical, Biotechnology $1.4M–$462M
Share Capital
VC Fund
6 China, United States, Colombia Series A, Series B, Seed Health Care, Medical, Biotechnology $142k–$57M
Fortune Venture Capital
VC Fund
5 China, Japan, United States Series A, Series B, Seed Manufacturing, Software, Information Technology $425k–$73M
SZHTI Group
VC Fund
5 China, United States Series A, Angel Manufacturing, Electronics, Semiconductor $425k–$14M
Sunland Fund
VC Fund
5 China Series B, Series A, Seed Medical, Health Care, Medical Device $1.4M–$28M
Oriza Holdings
VC Fund
5 China, United States, Canada Series A, Series B, Series C Manufacturing, Health Care, Biotechnology $1.7M–$200M
Apricot Capital
VC Fund
5 China, United States, Hong Kong Series A, Seed, Series B Biotechnology, Health Care, Medical $3M–$58M
Volcanics Venture
VC Fund
4 China, United States, Hong Kong Series A, Series B Health Care, Artificial Intelligence, Biotechnology $425k–$60M
Tsinghua Innovation Ventures
VC Fund
4 China Series A, Seed Manufacturing, Medical, Health Care $832k–$21M
Insight Capital
VC Fund
4 China, Thailand, United Kingdom Series A, Seed, Series C Health Care, Medical, Medical Device $2.8M–$100M
Green Pine Capital Partners
VC Fund
4 China, United States, Canada Series A, Series B, Angel Software, Biotechnology, Manufacturing $425k–$150M
Tasly Capital
VC Fund
4 China Series B, Series A, Seed Medical, Medical Device, Health Care $14M–$43M
ASBV
VC Fund
4 China, Australia, Hong Kong Seed, Series A, Angel Health Care, Medical, Biotechnology $425k–$31M
Qiaojing Capital
VC Fund
4 China Series A, Series B, Angel Health Care, Medical, Medical Device $1.4M–$35M
Frees Fund
VC Fund
4 China, United States, Singapore Series A, Seed, Angel Artificial Intelligence, Health Care, Biotechnology $425k–$35M
Huagai Capital
VC Fund
4 China, United States, Germany Series A, Series B, Angel Health Care, Biotechnology, Medical $425k–$90M
HY Capital
VC Fund
4 China, United States Series A, Seed, Series B Health Care, Medical, Medical Device $83k–$28M
GSR United Capital
VC Fund
3 China, United States, Singapore Series A, Seed, Series B Manufacturing, Artificial Intelligence, Robotics
Prosperico Ventures
VC Fund
3 China, United States Series A, Seed, Series B Medical, Health Care, Biotechnology $4.3M–$150M
Tiantu Capital
VC Fund
3 China, United States, Japan Series A, Series B, Series C Food and Beverage, E-Commerce, Health Care
Yuanhui Chuangyi
VC Fund
3 China Seed, Series A Medical Device, Beauty, Industrial
CASH Capital
VC Fund
3 China, United States Series A, Series B, Series C Health Care, Biotechnology, Manufacturing
Qingsong Fund
VC Fund
3 China, United States, Canada Series A, Angel, Seed Manufacturing, Internet, Education
CMB International Capital Corporation
VC Fund
3 China, United States, Japan Series B, Series A, Series C Biotechnology, Health Care, Manufacturing
Northern Light Venture Capital
VC Fund
3 China, United States, South Korea Series A, Series B, Seed Health Care, Medical, Biotechnology
Co-Stone Venture Capital
VC Fund
3 China, United States, Hong Kong Series B, Series A, Series C Manufacturing, Semiconductor, Health Care
Access all 1197 VC funds in China Medical Device startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Qiming Venture Partners
VC Fund · Shanghai, Shanghai, China · 13 investments in China Medical Device startups

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 740
  • Round size: Series A $5M–$64M; Series B $10M–$100M; Series C $15M–$142M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely still investing — raised $887M in 2023

Portfolio highlights

  • Plum — Plum is an e-commerce platform for second-hand fashion products. It works as a one-stop consignment service platform that provides filming, sales, customer service, sale, and a full set of consignment services. Plum was founded on 2015 and is headquartered in Beijing, China.
  • Bytelumio — Bytelumio creates advanced all-optical networks that deliver high-speed connections of 800G and 1.6T for data centers.
  • Guangjing Energy — Guangjing Energy is a perovskite solar cell module developer, dedicated to the R&D of long-life large-area perovskite solar cell modules.
Show all investments...

Cowin Capital
VC Fund · Shenzhen, Guangdong, China · 13 investments in China Medical Device startups

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 281
  • Round size: Seed $1.4M–$20M; Series A $4.3M–$43M; Series B $2.8M–$50M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — raised $75M in 2014

Portfolio highlights

  • Cosminde — Cosminde is a developer of gastroenterology soft electronic endoscope products.
  • AVIC Robots — AVIC is an emerging high-tech company specialising in artificial intelligence and service robots.
  • Moment Control Xinchen — Moment Control Xinchen is a manufacturer of technologically advanced industrial control systems.
Show all investments...

HSG
VC Fund · Beijing, Beijing, China · 12 investments in China Medical Device startups, 10 in the past 12 months

We help founders build enduring companies.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 751
  • Round size: Series A $4.4M–$100M; Series B $12M–$200M; Series C $26M–$214M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
  • Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
  • Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Show all investments...

Shunwei Capital
VC Fund · Beijing, Beijing, China · 11 investments in China Medical Device startups

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Internet
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 418
  • Round size: Series A $1.4M–$41M; Series B $8.2M–$50M; Series C $20M–$130M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $1.2B in 2018

Portfolio highlights

  • CertiK — CertiK, the largest Web3 security service provider, uses AI and formal verification to protect and monitor smart contracts and protocols, securing the Web3 ecosystem.
  • Leqi Intelligent — Leqi Intelligent is specialized in research and development in the field of intelligent short-term transportation through AIoT intelligent interconnection, intelligent somatosensory interaction, intelligent robot technology, intelligent algorithms, electronic control, electric drive, battery BMS system, and industrial design.
  • Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
Show all investments...

BioVenture
VC Fund · Suzhou, Jiangsu, China · 11 investments in China Medical Device startups

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 165
  • Round size: Seed $7.1M–$20M; Series A $1.9M–$43M; Series B $3M–$73M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Jiamuyao Medical — Jiamuyao Medical specialized in developing an energy platform for the comprehensive treatment of complex intravascular lesions.
  • Xingyuanzhi Robotics — Xingyuanzhi Robotics strives to develop multimodal spatial intelligence systems and a universal embodied brain capable of comprehending and interacting with the physical world.
  • MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
Show all investments...

CD Capital
VC Fund · Shanghai, Shanghai, China · 10 investments in China Medical Device startups

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 69
  • Round size: Seed $1.4M–$14M; Series A $1.4M–$32M; Series B $7.1M–$34M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Pipi Bear
  • Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
  • Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Show all investments...

Lilly Asia Ventures
VC Fund · Shanghai, Shanghai, China · 10 investments in China Medical Device startups

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 212
  • Round size: Series A $14M–$100M; Series B $25M–$112M; Series C $28M–$259M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
  • Ronovo Surgical — Founded in 2019 and headquartered in Shanghai, Ronovo Surgical is founded by industry veterans from global leaders in surgical and industrial robotics, such as Intuitive Surgical, Johnson & Johnson, Medtronic and KUKA. Aiming to transform how surgery is performed in China, Ronovo is leveraging robust R&D capabilities and strategicpartnerships globally to accelerate the development of a broad portfolio of MIS and digital surgery solutions that exemplifies the core themes of simplicity, precision, and intelligence.
  • Alebund Pharmaceuticals — Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions.
Show all investments...

BIOCHING CAPITAL
VC Fund · Longgang, Guangdong, China · 9 investments in China Medical Device startups

BIOCHING CAPITAL is an investment management firm.

Show more...

Investment focus

  • Industry: Medical, Medical Device, Biotechnology
  • Stage:Angel, Series A, Seed
  • Geography: China

Investor stats

  • Total investments: 20
  • Round size: Angel $425k–$100M; Series A $14M–$14M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Lunke Medical — Lunke Medical focuses on the research, development, production, and sales of medical devices, with particular strength and expertise in high-pressure technologies. The company is committed to delivering safe, reliable, and innovative solutions by combining advanced engineering, strict quality control, and continuous technological advancement tomeet the evolving needs of the medical industry.
  • Taose Tuantuan — Taose Tuantua is a sex toy company that primarily offers TAOSETT sex toy academy and exquisite sex toy community store services.
  • Qinglan Jichuang — Qinglan Jichuang is a domestic high-performance intelligent endoscope innovative enterprise.
Show all investments...

BioTrack Capital
VC Fund · Shanghai, Shanghai, China · 9 investments in China Medical Device startups

BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 84
  • Round size: Seed $14M–$168M; Series A $3M–$43M; Series B $14M–$150M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • PrinoPharma — PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets.
  • Shenluo Medical — Shenluo Medical manufactures functional neural implantable medical devices.
  • LaNova Medicines — LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
Show all investments...

Taiyu Investment
VC Fund · 8 investments in China Medical Device startups

Taiyu Investment is an investment firm.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: China

Investor stats

  • Total investments: 28
  • Round size: Seed $4.3M–$7.4M; Series A $14M–$37M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Immunocan — Immunocan focuses on the development of fully human antibody animals, artificial chromosome carriers with independent intellectual property rights, focusing on tumor treatment, and developing antibody therapeutic drugs.
  • Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
  • Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Addor Capital
VC Fund · Nanjing, Jiangsu, China · 8 investments in China Medical Device startups

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

Show more...

Investment focus

  • Industry: Manufacturing, Semiconductor, Electronics
  • Stage:Series A, Series B
  • Geography: China, Hong Kong, Singapore

Investor stats

  • Total investments: 297
  • Round size: Series A $1.4M–$28M; Series B $11M–$43M
  • Lead/follow: 51% lead, 49% follow

Portfolio highlights

  • Letuo Technology — Letuo Technology is a ASIC chip design & manufacturing firm focused on architecture and back end design, RTL coding, DFT, and synthesis.
  • Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .
  • Mingjian Electronics — Mingjian Electronics is a radio frequency test equipment research and development firm as well as a national high-tech enterprise specializing in radio frequency test equipment.
Show all investments...

Haibang Capital
VC Fund · Hangzhou, Zhejiang, China · 8 investments in China Medical Device startups

Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Series A, Angel, Series B
  • Geography: China

Investor stats

  • Total investments: 43
  • Round size: Angel $425k–$2.8M; Series A $1.4M–$14M; Series B $10M–$71M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • XPTC — XPTC is a wafer slicing equipment developer, dedicated to the research, development, production, and sales of ultra-precision thinning cutting equipment and related consumables.
  • Wuwen Zhike — Wuwen Zhixing is an intelligent driving service provider dedicated to offering professional and cutting-edge integrated solutions for AI data and simulation verification, as well as developing AI data infrastructure and accelerators.
  • SynRx Therapeutics — Sanctuary Bio is a DNA damage repair drug developer, focusing on the field of DNA damage repair.
Show all investments...

IDG Capital
VC Fund · Beijing, Beijing, China · 8 investments in China Medical Device startups

IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support.

Show more...

Investment focus

  • Industry: Software, Internet, E-Commerce
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 725
  • Round size: Series A $3M–$112M; Series B $7.4M–$142M; Series C $15M–$200M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • RootCloud — ROOTCLOUD is an IIoT platform provider, which has created IIoT platforms that have satisfied the needs of customers worldwide.
  • Yuanfudao — Founded in 2012, Yuanfudao is the largest online live courseplatform servicing primary and secondary school students in China. With a paying userbase of over 1 million, Yuanfudao offers a comprehensive curriculum spanning fromprimary school English, Mathematical Olympiad to all-subject courses in secondaryschool. Its unique online feature and largepool of quality teachers enable students toaccess live online tutoring at home taught by national renowned teachers, benefitinghundreds of thousands of students across the country.
  • Bodor Laser — Bodor Laser is a manufacturing company engaged in the R&D, production, and marketing of laser cutting machines. The company's laser products are high powered and range from 25000W, 30000W, 40000W, and 22000W laser cutting machines. The company is also the highest ranked in 10kW+ laser cutting machine sales volume.
Show all investments...

Med-Fine Capital
VC Fund · Shanghai, Shanghai, China · 7 investments in China Medical Device startups

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 78
  • Round size: Seed $8M–$60M; Series A $2.8M–$40M; Series B $11M–$60M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $69M in 2019

Portfolio highlights

  • Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
  • Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
  • BV Laser — BV Laser is a manufacturer of medical beauty equipment.
Show all investments...

Legend Capital
VC Fund · Beijing, Beijing, China · 7 investments in China Medical Device startups

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 388
  • Round size: Series A $2.8M–$94M; Series B $12M–$113M; Series C $14M–$200M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $177M in 2021

Portfolio highlights

  • Pony.ai — Pony.ai is a startup that builds full-stack autonomous driving solutions. It is a pioneer in autonomous mobility technologies and services across the US and China, spearheading public-facing Robotaxi pilots in both markets. Pony.ai is committed to creating a safe and sustainable mobility future by delivering autonomous mobility everywhere.Thecompany was founded by James Peng and Tiancheng Lou in 2016 and is headquartered in Fremont, California, United States.
  • ESWIN Computing — ESWIN Computing provides research and development of RISC-V computing architecture.
  • Yosemite Clinic — Yosemite Clinic is a full-service clinic providing convenient walk-in medical services in a state-of-the-art environment in Central Pudong. They offer family medicine, internal medicine, surgery, orthopedics (sports medicine), dermatology, medical cosmetology, dentistry, gynecology, pediatrics, ophthalmology, anesthesiology, rehabilitationmedicine, medical imaging, laboratory, pharmacy and more. Their onsite facilities and equipment include CT, X-ray, Ultrasound, Laboratory and Operating Rooms. Their doctors come from China and across the world, enabling us to serve you in many languages including, English, Japanese, Malay, Mandarin Chinese and Cantonese.
Show all investments...

Dalton Venture
VC Fund · Shanghai, Shanghai, China · 7 investments in China Medical Device startups

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: China, India, Canada

Investor stats

  • Total investments: 132
  • Round size: Seed $450k–$5M; Series A $2.8M–$17M; Series B $2.8M–$47M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • MacroLux — MacroLux Medical Technology Co., Ltd.
  • Kangyuan Medical — Kangyuan Medical is committed to developing, and manufacturing a new generation of precise and effective blood purification adsorption materials.
  • MaiKeWei Medical — MaiKeWei Medical is a national high-tech company. It has an entire system that includes production, sales, and R&D.
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 7 investments in China Medical Device startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 76
  • Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • DotBio — DotBio is a biopharmaceutical company specialized in next-generation domain antibody therapies.
  • Coastar Therapeutics — Coastar Therapeutics develops an erythrocyte enveloped virus delivery technology platform to perform repeated virus dosing. It evades recognition and attack by the immune system to address the challenges of systemic and repeated administration of drug therapies. Coastar's process technology and “red blood cell membranes only” enable thecompany to overcome the challenges of mass production and standardization, and has cost advantages. The company's first product targets oncolytic viruses and is developing ELCV solutions for other therapies.The company was founded in 2017 and is based in San Diego, CAlifornia.
  • Leadinno Medical Valley — Leadino Medical Valley is a producer of medical devices for neuroregulatory functions.
Show all investments...

Oriza Seed Capital (Oriza Yuandian)
VC Fund · Suzhou, Jiangsu, China · 7 investments in China Medical Device startups

Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Medical
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 141
  • Round size: Seed $213k–$14M; Angel $425k–$14M; Series A $1.4M–$90M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • DreamTech — DreamTech is an AI startup company focusing on native 3D generation.
  • Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
  • GeneQuantum Healthcare — GeneQuantum Healthcare (Suzhou) Co., Ltd. is a high-tech company that focuses on the research and development of innovative Bio-therapeutics.GeneQuantum was founded in August 2013 at Suzhou Industrial Park, and has built-up a world-class bio-conjugation technology platform, focusing on developing series of next generation anti-tumorAntibody-Drug-Conjugates (ADCs) with best-in-class potential. Securing this round of financing will significantly promote the development of current ADC candidates towards IND filling in both US and China, meanwhile further expanding the company's product pipeline.
Show all investments...

EFung Capital
VC Fund · Shenzhen, Guangdong, China · 7 investments in China Medical Device startups

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 68
  • Round size: Series A $1.4M–$76M; Series B $14M–$87M; Series C $14M–$71M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
  • Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
  • JGene Biotechnology — JGene Biotechnology is a research and development biotechnology company dedicated to the research and development of universal CAR-NK/T products from iPS. It is hoped that the large-scale production of CAR-NK/T from iPS will provide cancer patients with spot-type, price-friendly, and affordable new immune cell therapy products. Recentlyreceived angel round investment.
Show all investments...

CDH Investments
VC Fund · Kowloon City, Kowloon, Hong Kong · 6 investments in China Medical Device startups

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 272
  • Round size: Series A $7.3M–$198M; Series B $14M–$142M; Series C $14M–$300M
  • Lead/follow: 47% lead, 53% follow

Portfolio highlights

  • Spear Bio — Successive Proximity Extension Amplification Reaction (SPEAR) technology from Spear Bio enables ultra-sensitive biomarker detection using ultra-small samples.
  • Vision Medicals — Vision Medicals is a provider of pathogenic gene diagnostic services, focusing on infection-precise medical treatment, high-throughput sequencing-based pathogen metagenomics and CRISPR-based rapid diagnosis and other new technologies, effectively improving the detection ability of clinical pathogens and shortening The reporting cycle acceleratedthe development of the infection-accurate medical industry. The company developed a pathogenic nucleic acid enrichment technology with independent intellectual property rights for the detection of pathogenic micronucleic acids in clinical samples. The pathogen macro was established through the accumulation of pathogen detection big data. Genomics intelligent analysis and reporting system.
  • ReviR Therapeutics — ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Haiyuan Capital
VC Fund · Shenzhen, Guangdong, China · 6 investments in China Medical Device startups

Goldport Capital is a Shenzhen-based asset management company.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Semiconductor
  • Stage:Series A, Seed, Angel
  • Geography: China

Investor stats

  • Total investments: 64
  • Round size: Seed $1.4M–$14M; Angel $425k–$14M; Series A $1.4M–$55M
  • Lead/follow: 53% lead, 47% follow

Portfolio highlights

  • Tianyuanxing — Tianyuanxing is a general industrial embodied intelligent platform developer whose primary focus is on the research and development of the "TX01" wheeled chassis humanoid dual-arm robot.
  • Anxin Medical — Anxin Medical is a company dedicated to the research, development, production, and sales of innovative medical devices. The company focuses on advancing healthcare technology through continuous innovation, integrating cutting-edge science and engineering to create high-quality, reliable, and efficient medical products.
  • Hangzhou Atom — Hangzhou Atom focuses on the R&D of atomic-level high-end materials manufacturing equipment, specializing in vacuum chemical vapor deposition
Show all investments...

SND Ventures Group
VC Fund · Suzhou, Jiangsu, China · 6 investments in China Medical Device startups, 12 in the past 12 months

SND Ventures Group is a venture capital and private equity firm specializing in seed investments.

Show more...

Investment focus

  • Industry: Manufacturing, Semiconductor, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: China

Investor stats

  • Total investments: 79
  • Round size: Series A $1.4M–$21M; Series B $5.7M–$31M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Rongsu Technology — Rongsu Technology is a provider of metal wire feeding additive equipment and services.
  • Jipai Electromagnetic — Jipai Electromagnetic specializes in the manufacture of automobile components and accessories.
  • Sicui Thermal Control — Sicui Thermal Control focuses on the design of next-generation semiconductor and microelectronics thermal management solutions.
Show all investments...

Highlight Capital
VC Fund · Nanjin, Jiangsu, China · 6 investments in China Medical Device startups, 36 in the past 12 months

Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Portugal

Investor stats

  • Total investments: 154
  • Round size: Seed $8.5M–$73M; Series A $2.8M–$73M; Series B $7.6M–$70M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $563M in 2021

Portfolio highlights

  • Yixiu — Yixiu provides sleep health products such as smart wearables, smart home sleep scene hardware, sleep data analysis platforms, energy management apps, and more.
  • Yushi Space — Yushi Space is a liquid rocket developer that focuses on the development and manufacture of large-capacity, low-cost and rapidly reusable liquid rockets.
  • PoShell Robotics — PoShell Robotics is a general-purpose home robot, aiming to create a home-friendly and structurally stable robot.
Show all investments...

Matrix Partners China
VC Fund · Beijing, Beijing, China · 6 investments in China Medical Device startups

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 440
  • Round size: Seed $1.4M–$32M; Series A $2.8M–$60M; Series B $9.5M–$108M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Lexin — LexinFintech Holdings is an online consumer finance platform for educated young adults in China. As one of China's leading financial technology companies, Lexin integrates its e-commerce-driven installment finance platform, Fenqile, with advanced risk management technologies, the Company's Dingsheng online investment platform, and theCompany's Juzi Licai online investment platform for individual investors, to create a comprehensive consumer finance ecosystem. The Company utilizes technologies including big data, cloud computing and artificial intelligence to enable the near-instantaneous matching of user funding requests with offers from the Company's more than 30 funding partners, which include commercial banks, consumer finance companies, and other licensed financial institutions. By serving the credit needs of China's educated young adults, Lexin helps its more than 20 million registered users to enjoy a better quality of life through the use of better credit.
  • Ambilight — Ambilight focuses on smart and flexible thin-film innovation and manufacturing. The company has multiple international leading technologies, ranging from material synthesis, manufacturing to product design. Two innovation centers, located in Shenzhen and the US, are working strategically with multiple Fortune Global 500 companies.
  • Ucello Therapeutics — Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
Show all investments...

Marathon Venture Partners
VC Fund · Shanghai, Shanghai, China · 6 investments in China Medical Device startups

Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 63
  • Round size: Seed $7M–$13M; Series A $1.4M–$28M; Series B $14M–$462M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Fungifuture — Fungifuture is a synthetic biomaterials company specializing in the research and development and production of fungal fiber materials.
  • Ruize Health — Ruize Health is a commercial insurance company that focuses on health consumption and commercial insurance.
  • Fuxin Technology Innovation — Fuxin Kechuang is a high-tech company that specializes in offering detailed information solutions for the medical and healthcare industries. The business offers creative software solutions and services to a range of healthcare organizations, actively supports the digital transformation of healthcare, and uplifts the medical sector. The company hasgained recognition and has become a partner of big and medium-sized medical institutions and healthcare institutions by relying on its technological research and development power, service capabilities, and ecosystem of medical and health software.
Show all investments...

Share Capital
VC Fund · Shenzhen, Guangdong, China · 6 investments in China Medical Device startups

Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Colombia

Investor stats

  • Total investments: 112
  • Round size: Seed $142k–$6.9M; Series A $1.4M–$15M; Series B $2.8M–$57M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
  • SuperDimension Power — SuperDimension is dedicated to creating leading embodied intelligent brains and robot bodies.
  • Help Therapeutics — Help Stem Cell Innovations Co. Ltd. is the first biotechnology company in China to use iPSC-induced pluripotent stem cell technology to regenerate myocardial, liver, nerve and other tissues and organs. Relying on this core technology, Elp Regenerative Medicine is committed to building a national biological sample bank and cell preparation center,leading the frontier of cell therapy, promoting the clinical transformation of regenerative medicine, and solving the clinically unresolvable degenerative and functional impairment diseases. Reshape human health.
Show all investments...

Fortune Venture Capital
VC Fund · Shenzhen, Guangdong, China · 5 investments in China Medical Device startups

Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: China, Japan, United States

Investor stats

  • Total investments: 255
  • Round size: Seed $425k–$73M; Series A $1.4M–$41M; Series B $2.8M–$56M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — raised $780M in 2021

Portfolio highlights

  • Dishi Medical — Dishi Medical is a company that manufactures Ophthalmic Medical Devices and other micro-assisted robots supported by biotechnology.
  • Deep Robotics — Deep Robotics specializes in the application of the global quadruped robot industry. The founding team is rooted in Zhejiang University and has more than ten years of robotics research and development background. It is a high-tech company that attaches great importance to research and development and takes core technology as its maincompetitiveness. Sunshine has mastered the key core technology of quadruped robot motion control and has a number of independent and controllable intellectual property rights. The self-developed "Jueying" series of robots have reached the advanced level among similar products in the world and has been the first to be put into use in electric power, tunnel, fire protection, security, and other fields. Since its establishment in 2017, Yunshen has completed the R&D and sales layout of four series of products conducted multiple rounds of financing and built a complete organizational system. With the increasingly mature application of the quadruped robot industry, the company has entered a channel of rapid development.
  • Chance Pharmaceuticals — Chance Pharmaceuticals provides, discovers, develops, and commercializes inhalation therapies for the world’s debilitating diseases such as chronic obstructive pulmonary disease, asthma, pulmonary arterial hypertension, and central nervous system disorders.
Show all investments...

SZHTI Group
VC Fund · Shenzhen, Guangdong, China · 5 investments in China Medical Device startups

SZHTI Group is a company that provides asset management and financing services.

Show more...

Investment focus

  • Industry: Manufacturing, Electronics, Semiconductor
  • Stage:Series A, Angel
  • Geography: China, United States

Investor stats

  • Total investments: 119
  • Round size: Angel $425k–$1.4M; Series A $780k–$14M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Junyi Technology — Shenzhen Junyi Technology Co., Ltd. is one of the world's leading OLED vapor deposition metal mask manufacturers. Its business includes OLED metal mask R&D, production and manufacturing, as well as supporting cleaning and maintenance services. Its customers cover CSOT, Truly Semiconductor, Royole Technology, Wuhan Tianma, BOE and otherdomestic OLED panel companies.
  • Zhiqin Instruments — Zhiqin Instruments is an instrument supplier that offers full solutions for analysis and testing to important industries based on its own rapid detection mass spectrometer.
  • Yingshen Intelligence — Yingshen Intelligence is a robot developer that focuses in the research, growth, and application of embodied intelligence technology.
Show all investments...

Sunland Fund
VC Fund · Shanghai, Shanghai, China · 5 investments in China Medical Device startups

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

Show more...

Investment focus

  • Industry: Medical, Health Care, Medical Device
  • Stage:Series B, Series A, Seed
  • Geography: China

Investor stats

  • Total investments: 31
  • Round size: Seed $1.4M–$14M; Series A $1.4M–$14M; Series B $2.8M–$28M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • Aopeng Yiliao — Aopeng Yiliao is a developer of vascular interventional surgery robots.
  • Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
  • Yangshan Medical Technology — Yangshan Medical Technology is a Shanghai-based company specializing in dental surgery robots.
Show all investments...

Oriza Holdings
VC Fund · Suzhou, Jiangsu, China · 5 investments in China Medical Device startups

Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 189
  • Round size: Series A $1.7M–$43M; Series B $10M–$100M; Series C $14M–$200M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • TuringQ — Established in February 2021, TuringQ is committed to the research of quantum information. Through the R&D of lithium niobate on insulator (LNOI) photonic chips and femtosecond laser direct writing technology, the photon chips that enable large-scale photonic circuits integration can be prepared and an optical quantum system with a whole newlevel of scale and complexity can be built. At present, TuringQ has achieved leading advantages in photonic quantum chips, scientific research-grade photonic quantum computers, photonic quantum measurement and control systems, photonic quantum EDA software, and photonic quantum cloud platforms.
  • Zhongke Jiahe — Zhongke Jiahe develops compilation technology and aspires to build a universal, low-cost, high-performance fundamental software tool chain.
  • Supermag — Suzhou Supermag Intelligent Technology Co., Ltd. (hereinafter referred to as Suci Technology) is committed to the research and development, production and sales of maglev high-speed motors. With the design authorization of magnetic levitation compressors, magnetic levitation blowers, magnetic levitation pumps, etc., it provides core components suchas magnetic levitation motors, magnetic levitation bearings, magnetic levitation controllers, and displacement sensors.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Apricot Capital
VC Fund · Shanghai, Shanghai, China · 5 investments in China Medical Device startups

Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 44
  • Round size: Seed $10M–$41M; Series A $3M–$54M; Series B $14M–$58M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Vibrant — Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects tocontinuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization.It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.
  • Zhonghe Gene — Zhonghe Gene is a gene technology developer, primarily involved in the research and development of DNA biosynthesis technology.
  • Microtide Biotechnology — Microtide Biotechnology is an innovative company specializing in the field of in vivo cell therapy. The company is dedicated to advancing next-generation biomedical technologies that harness the body’s own cellular mechanisms for disease treatment, focusing on developing safe, effective, and precise therapeutic solutions to improve patient outcomesand redefine the future of regenerative medicine.
Show all investments...

Volcanics Venture
VC Fund · Changning, Shanghai, China · 4 investments in China Medical Device startups

Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Biotechnology
  • Stage:Series A, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 102
  • Round size: Series A $425k–$21M; Series B $5.7M–$60M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — raised $73M in 2018

Portfolio highlights

  • Alluxio — Accelerate AI workloads, increase GPU utilization, and reduce infrastructure costs with Alluxio's AI-optimized, highly-distributed cache.
  • Triastek — Triastek develops 3D printed medicines and the production facilities to manufacture them and has already filed patent applications for its technology.
  • Vision Medicals — Vision Medicals is a provider of pathogenic gene diagnostic services, focusing on infection-precise medical treatment, high-throughput sequencing-based pathogen metagenomics and CRISPR-based rapid diagnosis and other new technologies, effectively improving the detection ability of clinical pathogens and shortening The reporting cycle acceleratedthe development of the infection-accurate medical industry. The company developed a pathogenic nucleic acid enrichment technology with independent intellectual property rights for the detection of pathogenic micronucleic acids in clinical samples. The pathogen macro was established through the accumulation of pathogen detection big data. Genomics intelligent analysis and reporting system.
Show all investments...

Tsinghua Innovation Ventures
VC Fund · Haidian, Beijing, China · 4 investments in China Medical Device startups

Tsinghua Innovation Ventures is an investment management firm.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Health Care
  • Stage:Series A, Seed
  • Geography: China

Investor stats

  • Total investments: 87
  • Round size: Seed $832k–$14M; Series A $1.4M–$21M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Synaire
  • ROBO Medical — ROBO Medical is a medical robot research and development company.
  • Nano Semiconductor — Nano Semiconductor provides manufacturing, research, and development of semiconductor front-end defect detection equipment.
Show all investments...

Insight Capital
VC Fund · Beijing, Beijing, China · 4 investments in China Medical Device startups

Insight Capital is a venture capital firm focused on early-stage investment.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Seed, Series C
  • Geography: China, Thailand, United Kingdom

Investor stats

  • Total investments: 25
  • Round size: Seed $14M–$15M; Series A $2.8M–$14M; Series C $5.7M–$100M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — raised $74M in 2018

Portfolio highlights

  • Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
  • Iongen Therepeutics — Discovery of Novel Analgesics IonGen is a biotech company dedicated to the discovery of next-generation pain therapies without the addiction liabilities and side-effects associated with opioids.
  • Hangzhou Dasheng Technology — Hangzhou Dasheng is a high-tech enterprise specializing in the research and development of medical surgical robot systems, dedicated to advancing precision medicine through innovative technologies, integrating artificial intelligence, robotics, and minimally invasive surgical solutions to improve clinical outcomes, enhance surgeon capabilities, andprovide safer, more efficient healthcare services worldwide.
Show all investments...

Green Pine Capital Partners
VC Fund · Shenzhen, Guangdong, China · 4 investments in China Medical Device startups

Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 179
  • Round size: Angel $425k–$2.9M; Series A $1.4M–$100M; Series B $9.9M–$150M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $138M in 2019

Portfolio highlights

  • Enrikenuo — Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.
  • MindRank AI — MindRank AI is a developer of proprietary end-to-end AI-driven drug discovery platform (Molecule Pro™).
  • Sungen Biomedical — Sungen Biomedical is engaged in the development of first-in-class (FIC) antibody therapeutics.
Show all investments...

Tasly Capital
VC Fund · Tianjin, Guangdong, China · 4 investments in China Medical Device startups

Tasly Capital is an investment arm of Tasly, a Chinese pharmaceutical company.

Show more...

Investment focus

  • Industry: Medical, Medical Device, Health Care
  • Stage:Series B, Series A, Seed
  • Geography: China

Investor stats

  • Total investments: 13
  • Round size: Series A $14M–$28M; Series B $14M–$43M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • Enrikenuo — Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.
  • Deco Medical — Deco Medical is a myocardial repair service provider and an innovative medical device research and development enterprise.
  • Singular Medical — Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients.
Show all investments...

ASBV
VC Fund · Shenzhen, Guangdong, China · 4 investments in China Medical Device startups

ASBV focuses on early and mid-term venture capital investments.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: China, Australia, Hong Kong

Investor stats

  • Total investments: 27
  • Round size: Seed $3M–$14M; Angel $425k–$425k; Series A $1.4M–$31M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
  • Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
  • Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Show all investments...

Qiaojing Capital
VC Fund · Shanghai, Shanghai, China · 4 investments in China Medical Device startups

Qiaojing Capital is an investment firm that invests in the medical, consumer & supply chain financial management industries. Qiao Jing Capital's core operation team has experience in senior management positions in well-known asset management companies at home and abroad. The company's operations fully follow the leading models athome and abroad, and pursue strict risk management and efficient incentive mechanisms.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Series B, Angel
  • Geography: China

Investor stats

  • Total investments: 14
  • Round size: Series A $1.4M–$35M; Series B $9.9M–$14M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
  • Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
  • Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.
Show all investments...

Frees Fund
VC Fund · Beijing, Beijing, China · 4 investments in China Medical Device startups

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Biotechnology
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 198
  • Round size: Seed $1.4M–$14M; Angel $425k–$17M; Series A $1.4M–$35M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $130M in 2015

Portfolio highlights

  • SoundAI — Sound Technology is a science and technology innovation company that specializes in acoustics frontier technology and artificial intelligence interaction. It is committed to lead the more interactive experience of artificial intelligence in the real environment and realize the human-computer interaction vision that "listen to you and know whatyou think".
  • Neurodome — Neurodome is a manufacturer of non-invasive deep brain nerve modulation technology. It focuses on the research and development of non-invasive deep brain nerve modulation products.
  • Pulin Technology — Pulin Technology provides tools and materials for creating nanoimprints and contributes to the study and advancement of fundamental technologies.
Show all investments...

Huagai Capital
VC Fund · Beijing, Beijing, China · 4 investments in China Medical Device startups

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Germany

Investor stats

  • Total investments: 133
  • Round size: Angel $425k–$15M; Series A $1.4M–$63M; Series B $3.5M–$90M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: May invest from a new fund soon — raised $430M in 2018

Portfolio highlights

  • Baijun Biotech — Baijun Biotechnology is a major player in the field of biopharmaceutical R&D services due to its one-stop biotechnology R&D service platform, strong R&D skills, and extensive industry experience.
  • GenFleet Therapeutics — GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize thebody's own immune system.
  • MicuRx Pharmaceuticals — MicuRx discovers and develops novel antibiotics to combat drug resistant bacterial infections. Founded in 2007, MicuRx employs a hybrid U.S./China business model to capitalize on the global opportunities afforded by U.S. research and development coupled with the high-quality, cost-efficient infrastructure and scientific resources available inChina. This hybrid business model enables MicuRx to implement an accelerated global development strategy with a goal of completing Phase II trials for its drug candidates in both the United States and China.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
HY Capital
VC Fund · Changning, Shanghai, China · 4 investments in China Medical Device startups

HY Capital is a healthcare industry-focused investment firm that engages in early-stage investments, growth-stage investments.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: China, United States

Investor stats

  • Total investments: 21
  • Round size: Seed $83k–$14M; Series A $199k–$16M; Series B $14M–$28M
  • Lead/follow: 52% lead, 48% follow

Portfolio highlights

  • Only Sanbio — Only Sanbio is a synthetic biotechnology company integrating R&D, production, and sales. Itsmed vision is to focus on the field of great health and great beauty, based on synthetic biology technology
  • Kang Ruijian — Kang Ruijian is a developer of thermosensitive modified chitin hydrogel technology.
  • Linyan Medical — Linyan Medical is a high-tech company focusing on the combination of man and machine in metaverse medical surgery.
Show all investments...

GSR United Capital
VC Fund · Beijing, Beijing, China · 3 investments in China Medical Device startups

"Founded in 2009, GSR United Capital focuses on equity investment in high-tech industries, focusing on investment and M&A opportunities in advanced manufacturing, next-generation information technology, industrial Internet/digital enterprise services and other fields. GSR United Capital manages both RMB master funds and industrialfunds established with local governments. Since its establishment, GSR United Capital has received strong support from China's top market-oriented mother fund, government-guided fund, wealth management institutions, global 500 enterprises, listed companies and other institutions. Among them, investors with state capital background include Guochuang Yuanhe, Guochuang Kaiyuan, SDIC Unity Capital, China Merchants Venture, Suzhou Fund, Nanchang Industrial Control, Weifang Financial Holding Group, Dongguan Dongcheng, Zhangjiagang Jincheng Investment & Development Co., ltd, etc. Suzhou GSL Venture Capital Management Company, founded in 2011, is a private equity fund manager of the comprehensive fund of GSR United Capital (referred to as "" GSR United Capital ""), and completed the registration of private equity fund manager on May 20, 2014, with the serial number P1002246.""A+ stage is the main stage, the middle and late stage is the auxiliary"" The company focuses on equity investment in high-tech industry, focusing on the strategy of ""A+"" stage, with a capital allocation ratio of 60%. The project in this stage is between ""engineering"" and ""scale commercialization"", which is the ideal range of ""bargaining power"" and can win a high proportion of relative returns. At the same time, 40% of the project will be allocated in the middle and late stages. The middle and late stages refer to enterprises with IPO expectations within 2-3 years, and the investment will be completed within 60 months in the early stage of the fund investment period (exit will start in the third and fourth years), which will be used as the basic plate for anchoring returns.GSR United Capital has invested in more than 100 high-tech start-ups, including Great Wisdom Software (financial information terminal, 601519), eCARBON (high thermal conductivity graphite heat dissipation material, 603133), TZTEK (Precision, 688003), METRON (Diamond wire material, 603133) 300861), GTEP (sludge treatment and recycling, has started the board meeting), Niu (electric two-wheeler, NASDAQ: NIU), LATTICELIGHTING (LED silicon substrate technology and application), Freetech (unmanned driving), Marknum Technology (big data), xMate (light collaborative robot), TAGEIDRIVER (autonomous driving), HUIRUI (high-precision metal 3D printing), DYSO (CNC machine tool parts), NEWLINK GROUP (energy Internet), and many cross-border enterprises Industries such as LianLian (online payment), Xingyun Group (cross-border supply chain), Tec-Do (outbound brand digital marketing, Guangzhou), LAVA (smart guitar, Guangzhou), Shoplazza (outbound SaaS independent site construction tools, Guangzhou), E-ports (Internet for shipping industry), Chenhaiyun (sea-going compliance), Whalehouse.tech (intelligent warehousing), Huoyan (ABM intelligent marketing), Giiso (intelligent writing) and other excellent projects, which have won excess investment returns and social reputation. At present, the withdrawn projects include Great Wisdom Software (Financial information terminal, 601519), which has been fully withdrawn through listing, with return multiple reaching 8.96x, invested by GSR United Capital Phase I; TZTEK (Precision Measurement, 688003.STAR), fully exited through listing with return multiple reaching 2.74x, invested by GSR United Phase II and Botong Jinshi; eCARBON (high thermal conductivity graphite heat dissipation material, 603133), through the listing of all exit, return multiple reached 5x, invested by GSR United Capital Phase I Institute; METRON (Diamond Wire Materials, 300861), which was partially exited through listing with a return multiple of 4.5X and was invested by GSR United Phase III and Botong Jinshi Institute; Lebo Technology (cross-platform screen investment tool), partially exited through equity transfer, with a return multiple of 4.35x, invested by Botong Jinshi. Giiso (Intelligent Collaboration), which was partially withdrawn through equity transfer with a return multiple of 4.35x, was invested by Botong Jinshi.Zerowaste Asia Pte Ltd (ZA) was invested by Hongcheng RMB Fund, a subsidiary of GSR United Capital, in January 2017. It is committed to developing, producing and selling leading additives for heavy metal treatment. Its products have the characteristics of simple process, high efficiency, safety and environmental protection, and low cost. The company's valuation has grown from $58 million at the time of the investment to $142 million.Since February 2020, GSR United Capital has made more than 30 investments in the main fund. For example, it invested in Yuejing Technology (audio and video collaborative production tool) in February 2021, and the current multiple has reached 3.14 times. In September 2020, it invested in ZHICHUBAO.COM (procurement management SaaS platform), and the current multiple has reached 2.82 times. In April 2020, it invested in Starsee Intelligence (AI enabled military defense), and the current multiple has reached 2.81 times. Nahuo Technology Co., Ltd. received a subsequent round of investment from IDG, ZHICHUBAO.COM received a subsequent round of investment from Shunwei Capital, and Boqing Technology received a subsequent round of investment from KeyTone Ventures and Leaguer Capital."

Show more...

Investment focus

  • Industry: Manufacturing, Artificial Intelligence, Robotics
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 131
  • Lead/follow: no public data

Portfolio highlights

  • WeZhi Airlines — WeZhi Aviation focuses on medium and large general unmanned transport aircraft , and the company aspires to be a global provider of intelligent aviation-related technological goods and services.
  • Lanxin Computing — Lanxin Computing is a high-performance chip design company that focuses on the research and development of CPUs with RISC-V ecosystems.
  • Yifang Intelligent Control — Yifang Intelligent Control is a technological innovator engaged in high-end industrial control and industrial machine tool control systems.
Show all investments...

Prosperico Ventures
VC Fund · Shanghai, Shanghai, China · 3 investments in China Medical Device startups

Prosperico Ventures is a venture capital firm focused on healthcare and the high-tech industry.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, United States

Investor stats

  • Total investments: 14
  • Round size: Series A $4.3M–$60M; Series B $9.2M–$150M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Cytocares — Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.
  • Jiaohong Biology — Jiaohong Biology is a molecular diagnostic technology research and development and application service provider.
  • Yingte Micro Network — Yingte Micro Network is a medical device company focused on advancing innovation in energy-based therapeutic platforms and minimally invasive interventions, dedicated to improving patient outcomes through cutting-edge technology, precision engineering, and clinically proven solutions that enhance safety, efficiency, and recovery in modernhealthcare.
Show all investments...

Tiantu Capital
VC Fund · Shenzhen, Guangdong, China · 3 investments in China Medical Device startups

Tiantu Capital is a venture capital association.

Show more...

Investment focus

  • Industry: Food and Beverage, E-Commerce, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 118
  • Lead/follow: no public data

Portfolio highlights

  • Recorna Bio — Recorna Bio specializes in biotechnology, focusing on RNA editing and genome modifications through advanced research and development. They aim to innovate in genetic engineering, contributing to advancements in biomedicine and agriculture with cutting-edge technologies and scientific expertise.
  • RIGHTWAY — Ruiwei New Materials is a developer of biodegradable materials focused on applying them to the consumer market. It provides end-brand customers with integrated solutions from laboratory research and development to material processing and manufacturing.
  • Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
Show all investments...

Yuanhui Chuangyi
VC Fund · 3 investments in China Medical Device startups

Yuanhui Chuangyi is an investment firm.

Show more...

Investment focus

  • Industry: Medical Device, Beauty, Industrial
  • Stage:Seed, Series A
  • Geography: China

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Toll PATEO — Toll PATEO is a natural science, medical research and experimental development service provider.
  • Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
  • Xijian Technology — Xijian Technology is committed to advancing the industrialization of innovative human biomechanics imaging technology. It focuses on health disciplines such as sports rehabilitation, dermatology and beauty, and disease diagnosis and treatment.
Show all investments...

CASH Capital
VC Fund · Beijing, Beijing, China · 3 investments in China Medical Device startups

CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Series A, Series B, Series C
  • Geography: China, United States

Investor stats

  • Total investments: 78
  • Lead/follow: no public data

Portfolio highlights

  • Gene Cradle — Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases as well as chronic diseases.
  • Beijing KYKY Technology — KYKY is a supplier of vacuum acquisition and testing products for the Chinese market. Its products are relevant for electro-optics, ion optics, vacuum physics, and other technical engineering projects.
  • Huamei Titanium Technology — Huamei Titanium Technology specializes in the research, development, and manufacturing of liquid crystal phased array antennas.
Show all investments...

Qingsong Fund
VC Fund · Shenzhen, Guangdong, China · 3 investments in China Medical Device startups

Founded in June 2012 by Liu Xiaosong, Dong Zhanbin, and Su Wei, three Internet and investment circle veterans, Qingsong Fund is an early venture capital firm specializing in investment in education, social networking, consumerism, innovation, technology and applications. It manages four RMB funds with a total value of about RMB 2 billion. So far,it has invested in more than 140 companies, including 1 to 1 head, 1 DaDa English, squirrel AI, onion mathematics, wedding calendar, werewolf killing, flystep technology, HomeFacial. Pro and other star projects - 50% exit project returns more than 60 times, multiple project valuation multiples increased nearly 200 times, and educational projects have an average annual value increase of 500%. Among them, the Qingsong Smart Fund, which was newly established in 2018, focuses on the underlying technologies of the underlying AI and Smart Connect, as well as investment in such areas as smart healthcare, enterprise services and intelligent transportation applications. Liu Xiaosong, founding partner of Qingsong Fund, is a Ph.D. student at Tsinghua University. He invested in Tencent in 1999 and has a return on investment of tens of thousands of times. In 2000, he founded A8 New Media Group, which was successfully listed on the main board in Hong Kong in 2008. In 2015, he hatched in November 2018. Listed in Hong Kong stocks in the year. As a leading early investment institution in China, Qingsong Fund and its founding partners have repeatedly won Top 10 of Zero2IPO China's early investment institutions/investors, Top10 of China's education sector, Top100 of Chinese investors, and China's best early venture capital investment. Institution/Investor Top10; 36氪 China's new entertainment sector investment institutions Top10, online education sector investment institutions/investors Top10 and other mainstream awards.

Show more...

Investment focus

  • Industry: Manufacturing, Internet, Education
  • Stage:Series A, Angel, Seed
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 124
  • Lead/follow: no public data

Portfolio highlights

  • Volant Aerotech — Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.
  • Shufang New Energy — Shenzhen Sufang New Energy focuses on the research, development, and production of lithium-rich manganese-based cathode materials.
  • Tongwei New Energy — Tongwei New Energy is a company that manufactures zero-carbon solid oxide fuel cells. Its major product is distributed zero-carbon power plants.
Show all investments...

CMB International Capital Corporation
VC Fund · Central, Hong Kong Island, Hong Kong · 3 investments in China Medical Device startups

CMB International Capital Corporation is an investment banking firm that offers comprehensive professional services and financial advisory services. It provides mergers and acquisitions, initial public offering, equity underwriting, company restructuring, project financing, and business consulting services. CMB International Capital Corporationprovides corporate finance, asset management, wealth management and securities brokerage services. Additionally, it offers debt financing and transaction advisory services, placement of shares and refinancing for listed companies. CMB International Capital Corporation’s clientele include institutional, corporate and individual customers both domestic and overseas. It began operation in 1987, with its headquarters in Central in Hong Kong as a subsidiary of China Merchants Bank.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 109
  • Lead/follow: no public data

Portfolio highlights

  • Xiaoyu Zhizao — Xiaoyu Zhizao is an industrial robot manufacturer, focusing on industrial robot manufacturing, intelligent robot research and development.
  • SeeYA Technology — SeeYA Technology is a high-tech company specializing in R&D, design, production and sales of new-generation semiconductor OLEDoS display, and providing customers with micro-display components, modules and related solutions. There is a comprehensive product line to full fill different demands from AR/VR, drones, thermal devices, nightvision equipment etc.
  • Deep Robotics — Deep Robotics specializes in the application of the global quadruped robot industry. The founding team is rooted in Zhejiang University and has more than ten years of robotics research and development background. It is a high-tech company that attaches great importance to research and development and takes core technology as its maincompetitiveness. Sunshine has mastered the key core technology of quadruped robot motion control and has a number of independent and controllable intellectual property rights. The self-developed "Jueying" series of robots have reached the advanced level among similar products in the world and has been the first to be put into use in electric power, tunnel, fire protection, security, and other fields. Since its establishment in 2017, Yunshen has completed the R&D and sales layout of four series of products conducted multiple rounds of financing and built a complete organizational system. With the increasingly mature application of the quadruped robot industry, the company has entered a channel of rapid development.
Show all investments...

Northern Light Venture Capital
VC Fund · Beijing, Beijing, China · 3 investments in China Medical Device startups, 7 in the past 12 months

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 234
  • Lead/follow: no public data

Portfolio highlights

  • iRegene — iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases.
  • Wala English — Wala English is a provider of comprehensive full-process AI contextual learning services, leveraging artificial intelligence to deliver personalized, immersive language learning experiences that adapt to each learner’s needs, context, and progress throughout their educational journey.
  • Hertz Life Science Technology — Hertz Life Science Technology uses virus-like particle VLPs technology to develop animal and human vaccines.The company has several underlying core patented technologies and has established a stable and efficient research and development platform based on the Jiyin Biomedical Transformation (Greater Bay Area) base, and actively promotes theresearch and development of vaccines.At present, the company has carried out extensive and in-depth cooperation with large enterprises such as Qingdao Yibang and Wen's Group, and its R&D strength has been highly recognized by peers and upstream and downstream enterprises.
Show all investments...

Co-Stone Venture Capital
VC Fund · Shenzhen, Guangdong, China · 3 investments in China Medical Device startups, 9 in the past 12 months

Co-Stone Capital is a leading China based private equity firm headquartered in Shenzhen. Founded more than 16 years ago, Co-Stone is one of China's earliest private equity institutions. Co-Stone Capital focuses primarily on China domestic growth stage and Pre-IPO opportunities, basing investment decisions on a deep understanding of the Chineseeconomy and company specific growth patterns. We put heavy emphasis on stable growth in key industries, including TMT, healthcare, consumer products & services and advanced manufacturing. Co-Stone Capital approaches the capital markets with broad vision but detailed focus, maintaining an emphasis on value-adding services. We have invested in over 100 companies, the majority of which were lead investments and have successfully exited from 40 companies through IPO, M&A or reverse mergers. Our exit rates and ROI are far in excess of industry averages. Co-Stone Capital has assets under management in excess of 40 billion RMB, across funds covering private equity, venture capital, PIPE, M&A and fixed income. Co-Stone has a diverse capital base, with LPs ranging across large insurance groups, government guided funds, funds of funds, large corporations, entrepreneurs and high net worth individuals. Co-Stone Capital has received numerous accolades from Forbes, Zero2IPO,ChinaVenture and other industry publications which consistently rank us in the top 10. Co-Stone Capital is headquartered in Shenzhen, with offices in Beijing,Shanghai and Hefei.

Show more...

Investment focus

  • Industry: Manufacturing, Semiconductor, Health Care
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 140
  • Lead/follow: no public data

Portfolio highlights

  • PaXini Tech — All Scenario Application—Haptic Digitization and Tactile Technology
  • Ganwei Technology — Wuhan Ganwei Technology is a manufacturer of gas instruments and meters. Its main products include short optical path gas pools, online ultraviolet gas analyzers, gas sensors, oil and gas infrared spectroscopy logging tools, and high-precision automatic gas distribution instruments, etc., which are mainly used in environmental protection,Petrochemical and other fields.
  • Changzhou Fuxing Mechanical and Electrical Co. — Changzhou Fuxing Mechanical and Electrical Co. manufactures servo, brushless DC, and hybrid stepper motors.
Show all investments...

Medical Device VC funding in China at a glance

Stats across 971 deals from 1.2k investors.

1.2k
investors
in China Medical Device startups
971
deals
in China Medical Device startups
$14M
median round
in China Medical Device startups
40%
lead investors
lead at least one round
29%
Series A
most common funding stage

Access all 1197 VC funds in China Medical Device startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical Device VC Funds in China investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 1197 VC funds investing in China Medical Device startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists